Clinical Trial Update: Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study comparing two NN1250 insulin formulations with insulin aspart against insulin glargine plus insulin aspart in adults with Type 1 diabetes; trial r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin aspart (insulin aspart)
• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2015-11-16